No headlines found.
No press releases found.
No news found.
Virtus LifeSci Biotech Clinical Trials ETF is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the performance of the LifeSci Biotechnology Clinical Trials Index. Clinical Trials stage companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their experimental drugs.
Virtus Lifesci Biotech Clinical Trials ETF trades on the ARCA stock market under the symbol BBC.
As of April 19, 2024, BBC stock price declined to $24.88 with 2,085 million shares trading.
BBC has a market cap of $9.95 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, BBC stock traded as high as $52.41 and as low as $16.88.
BBC has underperformed the market in the last year with a price return of +6.8% while the SPY ETF gained +21.2%. BBC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +4.1% and -8.0%, respectively, while the SPY returned +4.3% and -3.5%, respectively.
BBC support price is $24.86 and resistance is $25.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BBC stock will trade within this expected range on the day.